FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076054383> ?p ?o ?g. }

• W2076054383 endingPage "529" @default.
• W2076054383 startingPage "521" @default.
• W2076054383 abstract "The role of immunosuppressive drugs in the treatment of idiopathic membranous nephropathy (IMN) remains controversial. The effect of treatment with prednisolone and azathioprine in patients with nephrotic-range proteinuria and biopsy-proven IMN from a single center (Sheffield Kidney Institute, Sheffield, UK) is described. In this retrospective study, 58 patients with IMN and nephrotic-range proteinuria were followed up for 4 years. Thirty-eight patients were treated with prednisolone (1 mg/kg body weight/d) and azathioprine (2 mg/kg body weight/d) orally for a median period of 26 months (range, 6 to 48 months). Twenty patients received no specific treatment for IMN and served as a control group. Clinical, biochemical, and histopathologic features at presentation were similar between the groups. Renal function (RF), measured by serum creatinine (Scr) level, deteriorated in both treated and control groups during the follow-up period. The median initial and final Scr levels (at the end of follow-up) in the treated group were 1.6 and 2. 1 mg/dL, respectively, and in the control group were 1.3 and 1.7 m/dL, respectively (P = not significant). Neither the rate of RF decline (measured by the slope of reciprocal of Scr against time) nor the proportion of patients with deteriorating RF differed significantly between the groups (37%, treated group; 30%, control group). A significant reduction in proteinuria was observed in both groups (P < 0.01, either group). Also, the rate of remission of nephrotic-range proteinuria was not significantly different between groups (55%, treated group; 65%, control group). The only prognostic factor that correlated with RF outcome (expressed by final Scr level) in a given patient was the mean proteinuria during follow-up in either group (r = 0.493; P < 0.01, treated group; r = 0.651; P < 0.01, control group). Adverse effects of immunosuppressive treatment were observed in nine patients (24%). These were serious in four patients (10%) and included squamous cell carcinoma (two patients), bacterial meningitis (one patient), and septicemia (one patient). In conclusion, treatment with prednisolone and azathioprine for patients with IMN did not show significant beneficial effects on the progression of disease. Furthermore, this treatment was associated with frequent and serious adverse effects." @default.
• W2076054383 created "2016-06-24" @default.
• W2076054383 creator A5022353804 @default.
• W2076054383 creator A5048387863 @default.
• W2076054383 creator A5066540630 @default.
• W2076054383 creator A5082972319 @default.
• W2076054383 creator A5087890792 @default.
• W2076054383 date "1999-09-01" @default.
• W2076054383 modified "2023-09-28" @default.
• W2076054383 title "Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?" @default.
• W2076054383 cites W143610178 @default.
• W2076054383 cites W1868079414 @default.
• W2076054383 cites W1973388794 @default.
• W2076054383 cites W1973546907 @default.
• W2076054383 cites W1979078959 @default.
• W2076054383 cites W2002034691 @default.
• W2076054383 cites W2005989846 @default.
• W2076054383 cites W2020987938 @default.
• W2076054383 cites W2034759249 @default.
• W2076054383 cites W2037365119 @default.
• W2076054383 cites W2045606073 @default.
• W2076054383 cites W2049465295 @default.
• W2076054383 cites W2051702141 @default.
• W2076054383 cites W2055609351 @default.
• W2076054383 cites W2058330927 @default.
• W2076054383 cites W2067857277 @default.
• W2076054383 cites W2076724580 @default.
• W2076054383 cites W2088193429 @default.
• W2076054383 cites W2094462520 @default.
• W2076054383 cites W2117915845 @default.
• W2076054383 cites W2123435722 @default.
• W2076054383 cites W2130275009 @default.
• W2076054383 cites W2260911688 @default.
• W2076054383 cites W4245487764 @default.
• W2076054383 cites W4256022872 @default.
• W2076054383 doi "https://doi.org/10.1016/s0272-6386(99)70081-8" @default.
• W2076054383 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10469864" @default.
• W2076054383 hasPublicationYear "1999" @default.
• W2076054383 type Work @default.
• W2076054383 sameAs 2076054383 @default.
• W2076054383 citedByCount "16" @default.
• W2076054383 countsByYear W20760543832012 @default.
• W2076054383 countsByYear W20760543832013 @default.
• W2076054383 countsByYear W20760543832014 @default.
• W2076054383 countsByYear W20760543832015 @default.
• W2076054383 crossrefType "journal-article" @default.
• W2076054383 hasAuthorship W2076054383A5022353804 @default.
• W2076054383 hasAuthorship W2076054383A5048387863 @default.
• W2076054383 hasAuthorship W2076054383A5066540630 @default.
• W2076054383 hasAuthorship W2076054383A5082972319 @default.
• W2076054383 hasAuthorship W2076054383A5087890792 @default.
• W2076054383 hasConcept C126322002 @default.
• W2076054383 hasConcept C126894567 @default.
• W2076054383 hasConcept C141071460 @default.
• W2076054383 hasConcept C159641895 @default.
• W2076054383 hasConcept C2775946357 @default.
• W2076054383 hasConcept C2776715498 @default.
• W2076054383 hasConcept C2776760755 @default.
• W2076054383 hasConcept C2778930706 @default.
• W2076054383 hasConcept C2779134260 @default.
• W2076054383 hasConcept C2779561371 @default.
• W2076054383 hasConcept C2780091579 @default.
• W2076054383 hasConcept C2780252810 @default.
• W2076054383 hasConcept C2780306776 @default.
• W2076054383 hasConcept C71924100 @default.
• W2076054383 hasConcept C90924648 @default.
• W2076054383 hasConceptScore W2076054383C126322002 @default.
• W2076054383 hasConceptScore W2076054383C126894567 @default.
• W2076054383 hasConceptScore W2076054383C141071460 @default.
• W2076054383 hasConceptScore W2076054383C159641895 @default.
• W2076054383 hasConceptScore W2076054383C2775946357 @default.
• W2076054383 hasConceptScore W2076054383C2776715498 @default.
• W2076054383 hasConceptScore W2076054383C2776760755 @default.
• W2076054383 hasConceptScore W2076054383C2778930706 @default.
• W2076054383 hasConceptScore W2076054383C2779134260 @default.
• W2076054383 hasConceptScore W2076054383C2779561371 @default.
• W2076054383 hasConceptScore W2076054383C2780091579 @default.
• W2076054383 hasConceptScore W2076054383C2780252810 @default.
• W2076054383 hasConceptScore W2076054383C2780306776 @default.
• W2076054383 hasConceptScore W2076054383C71924100 @default.
• W2076054383 hasConceptScore W2076054383C90924648 @default.
• W2076054383 hasIssue "3" @default.
• W2076054383 hasLocation W20760543831 @default.
• W2076054383 hasLocation W20760543832 @default.
• W2076054383 hasOpenAccess W2076054383 @default.
• W2076054383 hasPrimaryLocation W20760543831 @default.
• W2076054383 hasRelatedWork W2048507533 @default.
• W2076054383 hasRelatedWork W2102103650 @default.
• W2076054383 hasRelatedWork W2129198067 @default.
• W2076054383 hasRelatedWork W2160259911 @default.
• W2076054383 hasRelatedWork W2330154650 @default.
• W2076054383 hasRelatedWork W2799841742 @default.
• W2076054383 hasRelatedWork W2916219914 @default.
• W2076054383 hasRelatedWork W3117361317 @default.
• W2076054383 hasRelatedWork W4385591304 @default.
• W2076054383 hasRelatedWork W593504957 @default.
• W2076054383 hasVolume "34" @default.
• W2076054383 isParatext "false" @default.

• next